" as doctors and pharmaceutical companies commingle in growing numbers, critics say, it becomes difficult to judge whether these and other recommendations are truly free of industry influence. At least five of the 22 members on the panel of cholesterol specialists who set the guidelines reported receiving funding or grants at some point from companies selling or developing cholesterol-lowering drugs. Some of the key studies in the field were also funded by the companies.
''We just don't know whether or not we are looking at the best route to reducing cholesterol,'' said Sheldon Krimsky, a professor of urban and environmental policy and planning at Tufts University. ''You usually don't hear about industry lobbying unless something goes wrong. But I'm fairly confident that with billions of dollars going to pharmaceutical companies, something was happening behind the scenes.''
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ BOSTON GLOBE
http://www.boston.com/dailyglobe2/151/nation/Drug_makers_influence_pondered%2b.shtml
Drug makers' influence pondered Eye on US advice to cut cholesterol By Naomi Aoki, Globe Staff, 5/31/2001